(19)
(11) EP 1 229 920 A1

(12)

(43) Date of publication:
14.08.2002 Bulletin 2002/33

(21) Application number: 00977293.0

(22) Date of filing: 29.09.2000
(51) International Patent Classification (IPC)7A61K 31/70
(86) International application number:
PCT/US0041/038
(87) International publication number:
WO 0122/970 (05.04.2001 Gazette 2001/14)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 29.09.1999 US 156542 P

(71) Applicant: THE CLEVELAND CLINIC FOUNDATION
Cleveland, OH 44195 (US)

(72) Inventors:
  • SILVERMAN, Robert, H.
    Beachwood, OH 44120 (US)
  • RUSCH, Lorraine
    Elmsford, NY 10523 (US)

(74) Representative: Brasnett, Adrian Hugh et al
Mewburn EllisYork House23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) THERAPY WITH 2-5A AND INTERFERON